Antonio Gasbarrini to Coronavirus Infections
This is a "connection" page, showing publications Antonio Gasbarrini has written about Coronavirus Infections.
Connection Strength
0.174
-
Confirmed or unconfirmed cases of 2019 novel coronavirus pneumonia in Italian patients: a retrospective analysis of clinical features. BMC Infect Dis. 2020 Oct 19; 20(1):775.
Score: 0.028
-
The impact of SARS-CoV-2 pandemic on Oncologic and Degenerative Spine Surgery Department activity: the experience of Rizzoli Orthopaedic Institute under COVID-19 lockdown. Eur Rev Med Pharmacol Sci. 2020 07; 24(13):7519-7523.
Score: 0.028
-
Editorial - COVID-19 pandemic outbreak and the Latin rule of Bernard de Clairvaux. Have we forgotten the past? Eur Rev Med Pharmacol Sci. 2020 06; 24(12):7194-7195.
Score: 0.028
-
Editorial - COVID-19 and the microbiota: new kids on the block. Eur Rev Med Pharmacol Sci. 2020 05; 24(9):5189-5191.
Score: 0.028
-
"Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial". Trials. 2020 Oct 22; 21(1):875.
Score: 0.007
-
Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2020 10; 115(10):1722-1724.
Score: 0.007
-
Predicting intensive care unit admission and death for COVID-19 patients in the emergency department using early warning scores. Resuscitation. 2020 11; 156:84-91.
Score: 0.007
-
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications. Inflamm Bowel Dis. 2020 08 20; 26(9):1306-1314.
Score: 0.007
-
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic. J Ultrasound. 2020 Dec; 23(4):449-456.
Score: 0.007
-
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic. Gut. 2020 09; 69(9):1555-1563.
Score: 0.007
-
Hereditary haemorrhagic telangiectasia: A disease not to be forgotten during the COVID-19 pandemic. J Thromb Haemost. 2020 07; 18(7):1799-1801.
Score: 0.007
-
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre. United European Gastroenterol J. 2020 08; 8(7):775-781.
Score: 0.007
-
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel. Lancet Gastroenterol Hepatol. 2020 05; 5(5):430-432.
Score: 0.007